Yuyan Tan

3.5k total citations · 1 hit paper
69 papers, 2.1k citations indexed

About

Yuyan Tan is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Yuyan Tan has authored 69 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Neurology, 18 papers in Cellular and Molecular Neuroscience and 17 papers in Molecular Biology. Recurrent topics in Yuyan Tan's work include Parkinson's Disease Mechanisms and Treatments (42 papers), Neurological disorders and treatments (19 papers) and Balance, Gait, and Falls Prevention (10 papers). Yuyan Tan is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (42 papers), Neurological disorders and treatments (19 papers) and Balance, Gait, and Falls Prevention (10 papers). Yuyan Tan collaborates with scholars based in China, United States and Australia. Yuyan Tan's co-authors include Shengdi Chen, Chao Gao, Jingwen Jiang, Jun Liu, Shengdi Chen, Peter Jenner, Shengdi Chen, Qin Xiao, Jianfang Ma and Pei Huang and has published in prestigious journals such as NeuroImage, Scientific Reports and The Journal of Organic Chemistry.

In The Last Decade

Yuyan Tan

64 papers receiving 2.1k citations

Hit Papers

Microglia in neurodegenerative diseases: mechanism and po... 2023 2026 2024 2025 2023 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuyan Tan China 23 765 600 496 391 369 69 2.1k
Lingjing Jin China 25 696 0.9× 483 0.8× 217 0.4× 307 0.8× 357 1.0× 123 1.8k
Tommaso Schirinzi Italy 29 1.4k 1.9× 708 1.2× 328 0.7× 357 0.9× 813 2.2× 138 2.6k
Giulia Di Lazzaro Italy 21 933 1.2× 294 0.5× 223 0.4× 355 0.9× 277 0.8× 61 1.5k
Roberta Balestrino Italy 15 1.1k 1.4× 302 0.5× 212 0.4× 325 0.8× 379 1.0× 31 1.6k
Yvette Bordelon United States 26 1.6k 2.0× 499 0.8× 368 0.7× 404 1.0× 834 2.3× 70 2.5k
Qinyong Ye China 24 421 0.6× 617 1.0× 214 0.4× 378 1.0× 191 0.5× 83 1.7k
Claire Henchcliffe United States 30 1.6k 2.1× 1.2k 1.9× 345 0.7× 503 1.3× 910 2.5× 70 3.3k
Eng King Tan Singapore 25 1.2k 1.6× 606 1.0× 370 0.7× 361 0.9× 526 1.4× 71 2.3k
Kezhong Zhang China 22 822 1.1× 544 0.9× 283 0.6× 155 0.4× 303 0.8× 104 1.9k

Countries citing papers authored by Yuyan Tan

Since Specialization
Citations

This map shows the geographic impact of Yuyan Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuyan Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuyan Tan more than expected).

Fields of papers citing papers by Yuyan Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuyan Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuyan Tan. The network helps show where Yuyan Tan may publish in the future.

Co-authorship network of co-authors of Yuyan Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Yuyan Tan. A scholar is included among the top collaborators of Yuyan Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuyan Tan. Yuyan Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Guanglin, Pei‐Ming Huang, Shishuang Cui, et al.. (2024). Tai Chi improves non-motor symptoms of Parkinson's disease: One-year randomized controlled study with the investigation of mechanisms. Parkinsonism & Related Disorders. 122. 106109–106109.
3.
Tan, Yuyan, et al.. (2024). Salicylaldehyde-Cobalt(II)-Catalyzed C–H Alkoxylation of Indoles with Secondary Alcohols. The Journal of Organic Chemistry. 89(7). 4438–4443. 7 indexed citations
4.
Chen, Xiaohong, et al.. (2024). Mild C−H Alkoxylation of Aromatic Amides Catalyzed by Salicylaldehyde‐Co(II) Complexes. European Journal of Organic Chemistry. 27(34).
5.
Fu, Daan, Jia Liu, Qingqing Zhang, et al.. (2024). Identification of adipocyte infiltration-related gene subtypes for predicting colorectal cancer prognosis and responses of immunotherapy/chemotherapy. Heliyon. 10(13). e33616–e33616. 1 indexed citations
6.
Li, Gen, et al.. (2023). Effect of long-term Tai Chi training on Parkinson’s disease: a 3.5-year follow-up cohort study. Journal of Neurology Neurosurgery & Psychiatry. 95(3). 222–228. 10 indexed citations
7.
Yang, Yunfei, Lin Chen, Haitao Li, et al.. (2023). The causality between gut microbiome and liver cirrhosis: a bi-directional two-sample Mendelian randomization analysis. Frontiers in Microbiology. 14. 1256874–1256874. 11 indexed citations
9.
Gao, Chao, et al.. (2022). Pathogenesis, therapeutic strategies and biomarker development based on “omics” analysis related to microglia in Alzheimer’s disease. Journal of Neuroinflammation. 19(1). 215–215. 19 indexed citations
10.
Luo, Qi, Huidong Tang, Xinxin Xu, et al.. (2021). The Prevalence and Risk Factors of Cerebral Microbleeds: A Community-Based Study in China. Therapeutics and Clinical Risk Management. Volume 17. 165–171. 5 indexed citations
11.
Tan, Yuyan, Peter Jenner, & Shengdi Chen. (2021). Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future. Journal of Parkinson s Disease. 12(2). 477–493. 136 indexed citations
12.
Zhang, Yuqian, et al.. (2020). Prediction of Freezing of Gait in Patients With Parkinson’s Disease by Identifying Impaired Gait Patterns. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 28(3). 591–600. 45 indexed citations
13.
Tan, Yuyan, Weiguo Liu, Juanjuan Du, et al.. (2020). Validation of Revised Chinese Version of PD-CRS in Parkinson’s Disease Patients. Parkinson s Disease. 2020. 1–9. 4 indexed citations
14.
Liu, Jin, Gen Li, Yixi He, et al.. (2020). The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease. Frontiers in Genetics. 11. 952–952. 3 indexed citations
15.
Pan, Hong, Ruinan Shen, Mengyan Wang, et al.. (2019). Lack of Association Between DJ-1 Gene Promoter Polymorphism and the Risk of Parkinson’s Disease. Frontiers in Aging Neuroscience. 11. 24–24. 8 indexed citations
16.
Du, Juanjuan, Tian Wang, Pei Huang, et al.. (2018). Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy. Parkinsonism & Related Disorders. 57. 58–62. 19 indexed citations
17.
Tan, Yuyan, Elaine Delvaux, Jennifer Nolz, et al.. (2018). Upregulation of histone deacetylase 2 in laser capture nigral microglia in Parkinson's disease. Neurobiology of Aging. 68. 134–141. 22 indexed citations
18.
Tan, Yuyan, Li Wu, Zongbo Zhao, et al.. (2013). Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients. Parkinsonism & Related Disorders. 20(3). 308–313. 83 indexed citations
19.
Wang, Gang, Qi Cheng, Jie Zeng, et al.. (2008). Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale. Journal of the Neurological Sciences. 271(1-2). 153–157. 29 indexed citations
20.
Wang, Gang, Qi Cheng, Rui Zheng, et al.. (2006). Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China. Movement Disorders. 21(9). 1439–1443. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026